SARS-CoV-2 and SARS-CoV/HIV-1 Computational Models for Covid-19 Vaccine Development
Maryia Sivec and Roger Cooperman
The Sivec-Cooperman models of SARS-CoV-2 and SARS-CoV/HIV-1 genomes demonstrate that HIV-1 develops compensatory mutations that can restore its reduced fitness and outsmart vacine antagonists